Chemical compound lights up treatment-resistant cancers on imaging scans

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

China’s biotech boom is threatening US drugmakers’ dominance

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 22, 2025

Affimed narrows PhI/IIa focus; Bristol Myers pays Agenus $25M; Merck, Moderna start another PhIII cancer vaccine

Plus, news on Novartis’ recently-approved iptacopan and Acurx’s antibiotic. Affimed drops some indications from PhI/IIa trial: As the biotech reports promising mid-stage data for its

December 12, 2023

FDA OKs Farapulse Pulsed Field Ablation System for Intermittent Afib

The FDA approved the Farapulse pulsed field ablation (PFA) system for paroxysmal atrial fibrillation (Afib or AF), Boston Scientific announced on Wednesday. The device won

February 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.